Home  >  News
Eppen_CellXpert_Feb25
Waters_Ebook_Dec24
you can get e-magazine links on WhatsApp. Click here
News
  Barentz expands distribution partnership with Corum in Malaysia & Singapore,   February 08, 2025
  Dr Reddy’s inks pact with Henlius to commercialize HLX1, a biosimilar candidate in US & Europe,   February 06, 2025
  UK MHRA grants marketing authorization to Valneva’s chikungunya vaccine, Ixchiq,   February 06, 2025
  EMA committee recommends extension of marketing authorisation for Janssen-Cilag’s subcutaneous Rybrevant to treat advanced EGFR-mutated NSCLC,   February 04, 2025
  Bayer seeks European marketing approval for use of finerenone in adult patients with HF with a left ventricular ejection fraction (LVEF) of =40%,   February 04, 2025
  Curium introduces innovative 18F-PSMA PET radiopharmaceutical, Pylclari to treat prostate cancer in Estonia, Finland, Latvia, & Sweden,   January 29, 2025
  EMA accepts for review GSK’s MAA for depemokimab for use in asthma with type 2 inflammation and CRSwNP,   January 29, 2025
  Lupin and Avas launch NaMuscla in Italy to treat myotonia in adults with NDM disorders,   January 28, 2025
  ColdVentures enters exclusive distribution partnership with Medco Sports Medicine,   January 27, 2025
  EMA validates X4 Pharma’s marketing authorization application for mavorixafor to treat WHIM syndrome,   January 27, 2025
  Lupin receives US FDA marketing nod for generic Triumeq PD tablets for oral suspension to trteat HIV-1 infection,   January 24, 2025
  EMA committee approves Sanofi’s anti-CD38 therapy, Sarclisa in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma,   January 23, 2025
  Junshi Biosciences enters distribution and marketing partnership with LEO Pharma for toripalimab in Europe,   January 22, 2025
  Glenmark launches phytonadione injectable emulsion USP, 10 mg/mL single dose ampules,   January 21, 2025
  Poxel to receive sales-based payment and higher level of royalties from Sumitomo Pharma in Q1 2025 for Twymeeg achieving JPY 5 billion net sales in Japan,   January 21, 2025
  UK MHRA grants marketing authorization to Idorsia Pharma’s aprocitentan to treat adults with hypertension whose blood pressure cannot be controlled by other medications,   January 20, 2025
  China NMPA grants marketing authorization to IMPACT Therapeutics’ Senaparib for 1L maintenance therapy in ovarian cancer,   January 18, 2025
  In 2024 EMA recommends 114 medicines for marketing authorisation; 46 had a new active substance,   January 18, 2025
  Telix Pharma’s prostate cancer PET1 imaging agent, Illuccix receives European marketing approval,   January 18, 2025
  Handa Therapeutics acquires US FDA approved chronic myeloid leukaemia drug, Phyrago tablets from Nanocopoeia,   January 17, 2025

 Back
 
Avians_2025
Asia_Lab_Expo2025
chemexpoindia
ana-Lab-India_25
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram